Medical Malpractice
Tuesday, August 30, 2016
FDA approves Novartis biosimilar to Amgen's Enbrel
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novartis AG's biosimilar version of Amgen Inc's arthritis drug Enbrel.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment